Precision BioSciences Receives U.S. FDA Fast Track Designation for PBGENE-HBV, a First-In-Class Gene Editing Therapy Designed to Eliminate the Root Cause of Chronic Hepatitis B
DURHAM, N.C.–(BUSINESS WIRE)–Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS®... Read more.
Promega HiBiT-PsVLP Bioassay to Aid Global Vaccine Research
Promega HiBiT-PsVLP Bioassay enables simple, safe study without infectious viral particles. Assay supports collaboration between Charles River and CEPI’s Centralised... Read more.
MindMed Announces First Patient Dosed in Phase 3 Emerge Study of MM120 in Major Depressive Disorder (MDD)
– Emerge is the first Phase 3 study of lysergide D-tartrate (LSD) in MDD; primary endpoint will measure change from baseline in Montgomery-Åsberg Depression... Read more.
Pearce Announces Acquisition of JoeMax Telecom, LLC
PASO ROBLES, Calif.–(BUSINESS WIRE)–Pearce, a leading provider of asset management solutions for mission-critical electromechanical infrastructure, today... Read more.
Bidgely Sustains ‘Leader’ Position as Top Home Energy Management Provider by Guidehouse Research
Company’s rising leadership ranking attributed to emphasis on strategy, strong execution of AI-powered solutions globally LOS ALTOS, Calif.–(BUSINESS WIRE)–Bidgely... Read more.
908 Devices Announces Preliminary First Quarter 2025 Financial Results
At least 55% reported revenue growth from continuing operations compared to prior year BOSTON–(BUSINESS WIRE)–908 Devices Inc. (Nasdaq: MASS), a core... Read more.
Knife River Corporation Announces First Quarter 2025 Results Conference Call
BISMARCK, N.D.–(BUSINESS WIRE)–Knife River Corporation (NYSE: KNF), an aggregates-led, vertically integrated construction materials and contracting services... Read more.
Gerry Byrne Joins Academy Securities’ Advisory Board
NEW YORK–(BUSINESS WIRE)–Academy Securities, the nation’s first Post-9/11 veteran owned and operated investment bank, today announced the addition... Read more.
Sage Therapeutics to Report First Quarter 2025 Financial Results on Tuesday, April 29, 2025
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Sage Therapeutics, Inc. (NASDAQ: SAGE) today announced that it will host a live webcast on Tuesday, April 29, 2025,... Read more.
Ouster Announces Date for First Quarter 2025 Earnings Call
Company to Report Q1 2025 Results on May 8, 2025 SAN FRANCISCO–(BUSINESS WIRE)–$OUST–Ouster, Inc. (Nasdaq: OUST) (“Ouster” or the “Company”),... Read more.